BIO-IT World | May 3-5, 2022 | Boston, MA | Exhibiting
Visit Invicro’s booth #519.
ISMRM | May 7-12, 2022 | London | Abstract Presentations
More information on abstract presentations coming soon.
TIDES | May 9-12, 2022 | Boston, MA | Speaking
Talk title: The Role of Imaging and Analytics in the Development of Radiopharmaceuticals
Peptide Discovery, Preclinical and Clinical- ROOM 101
Main Conference – Day 2 (May 11) 4:45pm – 5:15pm
Speaker: Matthew Silva, Ph.D. | CEO
Radiopharmaceuticals offer unique diagnostic and therapeutic opportunities that require advanced nuclear medicine, molecular imaging, and analytical methods. This talk with survey the technologies, methods, and logistics required to support radiopharmaceutical drug discovery and development from preclinical studies through clinical trials.
Global Summit on Psychedelic-Assisted Therapies and Medicine | May 27-29, 2022 | Toronto | Attending
Brain & Brain PET | May 29- June 1, 2022 | Glasgow, Scotland | Attending
ASCO | June 3-7, 2022 | Chicago, IL | Exhibiting/Abstract Presentation
Visit Invicro inside the REALM IDx Booth #3177 to meet our team and learn how our clinical expertise can transform your oncology drug discovery and development.
SNMMI | June 11-14, 2022 | Vancouver, B.C. | Exhibiting/Abstract Presentation
Visit us at SNMMI Booth #1438 to learn how Invicro’s expertise transforms your preclinical through late-phase clinical research with complete radiopharmaceutical therapy solutions, research imaging solutions, clinical core lab capabilities and technology platforms, pathology services and advanced image visualization and analysis.
Join us on June 11 at 2 p.m. as Invicro’s Distinguished Scientist Jacob Hesterman, Ph.D. presents in the Image Quantification and Dosimetry in Radiopharmaceutical Therapy seminar reviewing case studies on Dosimetry in Multi-Center Trials.
DIA | June 19-23, 2022 | Chicago, IL | Exhibiting
Visit us at Booth #1031 to learn how Invicro’s expertise transforms your preclinical through late-phase clinical research with complete radiopharmaceutical therapy solutions, research imaging solutions, clinical core lab capabilities and technology platforms, pathology services and advanced image visualization and analysis.